---
title: "Access to and Cost of Cancer Drugs in a Changing Healthcare Landscape"
linktext: Agenda
slug: /reports/2018/1/3
---
<div class="full-report-container">
<div class="left-nav-container">
<left-navigation root="/reports/2018/1"></left-navigation>
</div>
<div class="report-container">

<table class="agenda-table">
<tbody>
<tr><td>

**8:30**</td><td>

Registration
</td></tr>
<tr><td>

**9:00**</td><td>

Welcome and Introductions
</td></tr>
<tr><td>

**9:45**</td><td>

Opening Presentations
- **Gary Gilliland, MD, PhD,** President and Director, Fred Hutchinson Cancer Research Center
- **Stacie Dusetzina, PhD,** Assistant Professor, Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy; Assistant Professor, Health Policy and Management, UNC Gillings School of Global Public Health
- **Paul Kluetz, MD,** Associate Director of Clinical Science, Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, Food and Drug Administration
</td></tr>
<tr><td>

**10:25**</td><td>

Break
</td></tr>
<tr><td>

**10:45** </td><td>

Brainstorm—Cancer Drug Access and Cost: Effects on Clinical Cancer Care
</td></tr>
<tr><td>

**11:35** </td><td>

Public Comment
</td></tr>
<tr><td>

**11:45** </td><td>

Lunch
</td></tr>
<tr><td>

**12:45** </td><td>

Brainstorm—Beyond Clinical Care: Market, Policy, Health System, and Regulatory Effects on Cancer Drug Access and Cost
</td></tr>
<tr><td>

**1:30** </td><td>

Input into Future Workshops: Prioritization of Focus Areas
</td></tr>
<tr><td>

**2:15** </td><td>

Break
</td></tr>
<tr><td>

**2:30** </td><td>

Input into Future Workshops: Topics and Questions
</td></tr>
<tr><td>

**3:40** </td><td>

Public Comment
</td></tr>
<tr><td>

**3:50** </td><td>

Wrap-Up and Next Steps
</td></tr>
<tr><td>

**4:00** </td><td>

Adjourn

</td></tr>
</tbody></table>

</div>
</div>
